At a glance
ClinicalIndex Comparison RecordN/ACompleted· 38 enrolled
Drug / intervention
Scatter corrected s-DCTdevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Clinical Evaluation of Primary Sampling Scatter Correction for Chest Tomosynthesis
In Brief
A clinical study evaluating Scatter corrected s-DCT for Pulmonary Nodule, Solitary and Pulmonary Nodule, Multiple. Completed, enrolled 38 participants across 1 site.
Detailed Summary
This is a study that will evaluate the utility of a scatter reduction technique in reducing dose and increasing the sensitivity of stationary digital chest tomosynthesis (s-DCT) in the detection of lung lesions.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
CountriesUnited States
CollaboratorsNational Cancer Institute (NCI)
Timeline
N/ACompletedFinished
2020202120222023202420252026
First PostedSep 2019
Enrollment StartAug 2020
Primary CompletionAug 2021
TodayJul 2026
First PostedSep 3, 2019
Enrollment StartAug 26, 2020
Primary CompletionAug 26, 2021
TodayJul 2, 2026
Enrollment to primary: 1 yearPosted 6.8 years ago
Interventions
Scatter corrected s-DCTdevice
All patients will have a breath held s-DCT scan in an anterior-posterior direction